GHK-CU 50mg
Copper Tripeptide-1 (Gly-His-Lys:Cu²⁺) — naturally occurring copper-peptide complex Over 150 published studies in dermatological and biochemical research Research-grade · Copper content verified via ICP-MS For in vitro ECM remodeling research only
For laboratory research use only. Not for human or veterinary consumption. SKU CU50.
Product details.
A molecule that programs genes
The Broad Institute’s Connectivity Map database revealed something striking: GHK-Cu affects the expression of roughly 4,048 human genes, approximately 6% of the genome. The pattern is consistent — upregulation of collagen, growth factors, integrins, elastin, decorin, and glycosaminoglycans, alongside downregulation of inflammatory mediators and excess metalloproteinases (Pickart & Margolina, Int J Mol Sci, 2018; PMC6073405).
Plasma levels tell their own story: roughly 200 ng/mL at age 20, dropping to about 80 ng/mL by age 60. The copper(II) ion is not just structural scaffolding — it is functionally active in roughly 30 copper-dependent enzyme systems.
Specifications
| Sequence | Gly-His-Lys:Cu²⁺ |
| Molecular Formula | C14H24CuN6O4 |
| Molecular Weight | 403.92 g/mol |
| CAS Number (GHK) | 49557-75-7 |
| CAS Number (GHK-Cu) | 89030-95-5 |
| Form | Lyophilized powder |
| Appearance | Blue to blue-purple powder |
| Solubility | Soluble in water |
| Quantity | 50mg per vial |
Research areas
Extracellular matrix remodeling
Pickart’s original work in rat wound models established the foundation — GHK-Cu influences collagen synthesis, decorin production, and glycosaminoglycan expression in fibroblast cultures (Nature, 1980; PubMed 7453802).
MMP regulation
Research has examined GHK-Cu’s effects on MMP-2, MMP-9, and TIMP balance — the metalloproteinase system that governs ECM turnover and remodeling.
Antioxidant interactions
Flow cytometry and ESR spin-trapping studies have characterized interactions with SOD activity, glutathione peroxidase pathways, and hydroxyl/peroxyl radical species.
Anti-inflammatory pathways
Preclinical work in cigarette smoke-induced lung inflammation models documented NF-κB pathway modulation and Nrf2 activation effects on inflammatory mediator expression (Pickart & Margolina, 2018).
GHK-Cu vs BPC-157
Different compounds, different mechanisms. GHK-Cu works through copper-dependent enzymatic pathways and gene expression modulation. BPC-157 works through connective tissue models and nitric oxide signaling. Heritage Labs USA carries both individually and together in the Glow 50/10/10 blend (GHK-Cu + BPC-157 + TB-500).
Research applications
- Peptide-metal complex characterization via LC-MS
- Fibroblast and keratinocyte cell culture studies
- ECM remodeling and collagen expression analysis
- Copper-dependent enzyme pathway research
- Gene expression profiling and Connectivity Map analysis
- Antioxidant and anti-inflammatory pathway screening
Quality and testing
Every Heritage Labs compound is manufactured to research-grade standards and shipped in protective packaging.
Storage
- Lyophilized: -20°C for long-term stability
- Reconstituted: 2-8°C, use within 30 days
- Protection: Shield from light and moisture
Frequently paired with
- BPC-157 5mg — Also available in Glow 50/10/10.
- Epithalon 10mg — Telomerase-focused research.
- SNAP-8 10mg — SNARE complex studies.
References
- Pickart L, et al. “Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells.” Nature. 1980;288(5792):715-717. PubMed 7453802
- Pickart L, Margolina A. “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.” Int J Mol Sci. 2018;19(7):1987. PMC6073405
- Park JR, et al. “The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice.” Oncotarget. 2016;7(36):58405-58417.
For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.
FDA Disclaimer. All products are for research use only (RUO) as defined by the FDA — not for diagnostic, human, or veterinary use. These products have not been evaluated and have not been approved by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.
Heritage Labs is a chemical supplier providing products strictly for laboratory research, analytical, and in-vitro purposes; it is not a compounding pharmacy or compounding facility under Section 503A, nor an outsourcing facility under Section 503B, of the Federal Food, Drug, and Cosmetic Act.




